This winter’s flu vaccine was a particularly bad match for the most common influenza strain in circulation, a new analysis from the Centers for Disease Control and Prevention found. Gizmodo reports: Thankfully, the flu season was much milder than usual for the second year in a row, as ongoing covid-19 precautions likely blunted the spread of flu as well. The estimates come from the CDC’s long-running surveillance program of people with suspected flu-like symptoms who visit various outpatient sites throughout the country. Overall, the odds of catching a case of confirmed flu were only slightly lower for vaccinated people, the researchers found. Against all flu strains detected at these sites, the vaccine was deemed to be 14% effective, as well as 16% effective at preventing cases of flu from A(H3N2) viruses, the predominant strain this winter. Numbers this low are far below the 50% threshold for a vaccine to be considered relatively useful, and they’re not even high enough to reach statistical significance.

In the words of the researchers, who published their results in the CDC’s Morbidity and Mortality Weekly Report, the vaccine “did not reduce the risk for outpatient respiratory illness caused by influenza A(H3N2) viruses that have predominated so far this season.” Flu vaccines, even in a good year, are far from perfect. The strains of influenza virus that infect humans are constantly evolving, meaning that scientists have to try to predict what these strains will look like during the next flu season so that they can match them to the strains included in the vaccine (the vaccine will usually include four strains at a time). This guessing game often results in a vaccine that’s around 50% to 60% effective, but sometimes, as is the case this year, the mismatch can get worse. It doesn’t help that this year’s main flu is H3N2, a subtype of flu already known for being harder to predict than others.

Read more of this story at Slashdot.

Over 170 million U.S.-born people who were adults in 2015 were exposed to harmful levels of lead as children, a new study estimates. The Associated Press reports: Researchers used blood-lead level, census and leaded gasoline consumption data to examine how widespread early childhood lead exposure was in the country between 1940 and 2015. In a paper published in the Proceedings of the National Academy of Sciences on Monday, they estimated that half the U.S. adult population in 2015 had been exposed to lead levels surpassing five micrograms per deciliter — the Centers for Disease Control and Prevention threshold for harmful lead exposure at the time.

The scientists from Florida State University and Duke University also found that 90% of children born in the U.S. between 1950 and 1981 had blood-lead levels higher than the CDC threshold. And the researchers found significant impact on cognitive development: on average, early childhood exposure to lead resulted in a 2.6-point drop in IQ. The researchers only examined lead exposure caused by leaded gasoline, the dominant form of exposure from the 1940s to the late 1980s, according to data from the U.S. Geological Survey. Leaded gasoline for on-road vehicles was phased out starting in the 1970s, then finally banned in 1996.

Read more of this story at Slashdot.

The Food and Drug Administration cleared a smartphone app from Tandem Diabetes Care to program insulin delivery for its t:slim X2 insulin pump, the company announced Wednesday. The Verge reports: It’s the first phone app for both iOS and Android to able to deliver insulin, the company said in a statement. Previously, delivery had to be handled through the pump itself. With this update, pump users will be able to program or cancel bolus doses of insulin, which are taken at mealtimes and are crucial in keeping blood glucose levels under control. “Giving a meal bolus is now the most common reason a person interacts with their pump, and the ability to do so using a smartphone app offers a convenient and discrete solution,” John Sheridan, president and CEO of Tandem Diabetes Care, said in a statement. […] Tandem said in the statement that it will launch the new bolus delivery update for select users this spring ahead of a wider launch this summer.

Read more of this story at Slashdot.

sciencehabit shares a report from Science.org: Three men paralyzed in motorcycle accidents have become the first success stories for a new spinal stimulation device that could enable faster and easier recoveries than its predecessors. The men, who had no sensation or control over their legs, were able to take supported steps within 1 day of turning on the electrical stimulation, and could stroll outside with a walker after a few months, researchers report today. The nerve-stimulating device doesn’t cure spinal cord injury, and it likely won’t eliminate wheelchair use, but it raises hopes that the assistive technology is practical enough for widespread use.

For now, sending commands to the device is cumbersome. Users must select their desired movement on a tablet, which sends Bluetooth commands to a transmitter worn around the waist. That device must be positioned next to a ‘pulse generator’ implanted in the abdomen, which then activates electrodes along the spine. Setting up to use the stimulation takes 5 to 10 minutes. But the next generation of devices should allow users to activate the pulse generator by giving voice commands to a smartwatch. The company behind the technology plans to test this newer mobility system in a multisite clinical trial of 70 to 100 participants that the team hopes will lead to U.S. regulatory approval. The researchers reported their findings in the journal Nature Medicine.

Read more of this story at Slashdot.

“Scientists have made the first steps to develop an atlas of world cancer, hoping it will bring us closer to a cure,” reports the Telegraph.

“A map showing stark differences in the incidence of 10 types of cancer between Spain and Portugal has sparked a race to pinpoint causes and risk factors people should avoid.”

It shows huge differences for people living only a short distance apart, sometimes across the border between Spain and Portugal, and others occurring within the same country. Scientists say it will take years to solve the puzzle completely but are confident that the map provides the pieces. There are easier questions and more complex riddles. But it all points to environmental factors — as opposed to genetics — playing a major role in causing cancers.

The lung cancer map tells a clear story of far higher levels of smoking tobacco in Spain than in Portugal, with the latter country showing a consistent hue of dark blue for a lower risk of mortality, while Spain has large areas lit up in red, at least on the map representing men. Twenty per cent of Spanish adults are daily smokers, compared with just over 11 per cent in Portugal. But the data from cancer of the larynx, also linked to smoking, tells a vastly different story, with a high mortality risk for men shown straddling the border in southern Portugal and south western Spain, as well as patches in the north of both countries. “The lung cancer and smoking connection is very clear, so why in other cancers that have a strong link with tobacco are we seeing such surprising differences?” asks Pablo Fernández-Navarro, the lead co-ordinator of the atlas from the Spanish side.

“This is what is so fantastic. If whole countries had uniform levels of mortality, the maps would be in plain colours. Given that it is not the case, now we have to investigate and explain these differences, eliminating one factor after another,” Fernández-Navarro told The Telegraph.

In the case of larynx cancer, the Spanish epidemiologist says the map confirms that smoking is by no means the only risk factor, and that other elements must also be at work, from alcohol intake to levels of pollutants such as asbestos or petrochemicals in the environment.

Thanks to Slashdot reader Bruce66423 for sharing the link.

Read more of this story at Slashdot.

An intelligence panel investigating the cause of a spate of mysterious incidents that have struck dozens of US officials across the globe has said that some of the episodes could “plausibly” have been caused by “pulsed electromagnetic energy” emitted by an external source, according to an executive summary of the panel’s findings released Wednesday. CNN reports: But the panel stopped short of making a definitive determination, saying only that both electromagnetic energy and, in limited circumstances, ultrasound could explain the key symptoms — highlighting the degree to which the murky illness known colloquially as “Havana Syndrome” has remained one of the intelligence community’s most stubborn mysteries. “We’ve learned a lot,” an intelligence official familiar with the panel’s work told reporters, speaking on anonymity under terms set by the Office of the Director of National Intelligence. “While we don’t have the specific mechanism for each case, what we do know is if you report quickly and promptly get medical care, most people are getting well.”

The scientific panel emphasized that the cases it studied were “genuine and compelling,” noting that some incidents have affected multiple people in the same space and clinical samples from a few victims have shown signs of “cellular injury to the nervous system.” An executive summary of the panel’s work provided new details about how the government is categorizing cases as possible Havana Syndrome, a clinically vague illness that has long frustrated firm diagnosis because victims have suffered from such a diverse array of symptoms. Although officials declined to say how many cases the panel examined as part of its inquiry, they said they studied cases that met four “core characteristics”: the acute onset of sounds or pressure, sometimes in only one ear or on one side of the head; simultaneous symptoms of vertigo, loss of balance and ear pain; “a strong sense of locality or directionality”; and the absence of any known environmental or medical conditions that could have caused the other symptoms.

Both pulsed electromagnetic energy, “particularly in the radiofrequency range,” and ultrasonic arrays could feasibly cause the four core symptoms, the panel found. Both could originate from “a concealable source.” But ultrasound can’t travel through walls, the panel found, “restricting its applicability to scenarios in which the source is near the target.”
Sources of radiofrequency energy, on the other hand, are known to exist, “could generate the required stimulus, are concealable, and have moderate power requirements,” the panel said. “Using nonstandard antennas and techniques, the signals could be propagated with low loss through air for tens to hundreds of meters, and with some loss, through most building materials.” But intelligence officials familiar with the panel’s work emphasized that important information gaps remained, forestalling them from reaching firmer conclusions. The experts panel also ruled out so-called psycho-social factors. They also ruled out “ionizing radiation, chemical and biological agents, infrasound, audible sound, ultrasound propagated over large distances, and bulk heating from electromagnetic energy.”

“The panel made seven recommendations, including developing better biomarkers that are ‘more specific and more sensitive for diagnosis and triage’ of cases,” reports CNN. “It also recommended utilizing ‘detectors’ and obtaining ‘devices to aid research.’ Finally, officials urged swift action by medical officials whenever a case is reported, emphasizing that individuals who have been treated immediately after an event have improved.”

Read more of this story at Slashdot.

Friday the results of several large studies showed that getting a third Covid vaccine “booster shot” dramatically decreased infections from the Omicron variant.

And now the Times of Israel reports that the country’s Health Ministry “said on Sunday that the fourth vaccine dose for those aged 60 and up offers a threefold protection against serious illness and twofold protection against infection in the current wave driven by the Omicron variant.”

The ministry said the figures are the result of initial analysis by experts from various leading academic and health institutions, and compares the fourth vaccine with those who received three doses at least four months ago.
The figures are based on 400,000 Israelis who received the fourth vaccine and 600,000 who received three doses, with the ministry stressing that the methodology is similar to previous papers the experts have published in the peer-reviewed New England Journal of Medicine.

Read more of this story at Slashdot.

Slashdot reader eastlight_jim writes:

Scientists from the University of Oxford have today published a study in Clinical Cancer Research which shows that they can use a technique called NMR (nuclear magnetic resonance) metabolomics analysis to identify patients with cancer. Specifically, they identify patients with cancer from within a population of generally unwell patients with non-specific symptoms like fatigue and weigh-loss — a traditionally hard-to-diagnose cohort.

The technique works because the NMR identifies small molecules called metabolites in the blood of patients and this information can then be used by machine learning to recognise patterns of metabolites specific to cancer, as well as identifying patients whose cancer has already spread.

The Guardian reports:
If validated, the test could enable cancer patients to be identified earlier, when they are more likely to respond to treatment, and help flag up who could benefit from early access to drugs designed to tackle metastatic cancer.

The test can also tell if the disease has spread.

There is currently no clear route through which someone with nonspecific symptoms that could be cancer is referred for further investigation…. “The problem we’ve had in the past is that if they do have cancer, that cancer is growing all the time, and when they come back the cancers are often quite advanced,” said Dr James Larkin, of the University of Oxford, who was involved in the research. Although it is difficult to know precisely how many individuals fall into this category, “it is likely to be tens of thousands of patients across the UK,” Larkin said.

Read more of this story at Slashdot.

New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King’s College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously. King’s College London reports: The research, published in The Journal of Psychopharmacology, is an essential first step in demonstrating the safety and feasibility of psilocybin — a psychedelic drug isolated from the Psilocybe mushroom — for use within controlled settings alongside talking therapy as a potential treatment for a range of mental health conditions, including treatment-resistant depression (TRD) and PTSD. Current treatment options for these conditions are ineffective or partially effective for many people, resulting in a significant unmet need. Early research has indicated a potential for psilocybin therapy to treat these groups, but no trials have been undertaken at the scale needed for regulatory approval to make the therapy available.

The trial is the first of its kind to thoroughly investigate the simultaneous administration of psilocybin. 89 healthy participants with no recent (within 1 year) use of psilocybin were recruited. 60 individuals were randomly picked to receive either a 10mg or 25mg dose of psilocybin in a controlled environment. In addition, all participants were provided with one-to-one support from trained psychotherapists. The remaining 29 participants acted as the control group and received a placebo, also with psychological support. Participants were closely monitored for six to eight hours following administration of psilocybin and then followed up for 12 weeks. During this time, they were assessed for a number of possible changes, including sustained attention, memory, and planning, as well as their ability to process emotions. Throughout the study, there were no instances of anyone withdrawing from the study due to an adverse event, and no consistent trends to suggest that either of the psilocybin doses had any short- or long-term detrimental effects on participants.

Read more of this story at Slashdot.

fahrbot-bot shares a report from The New York Times: What if something in the blood of an athlete could boost the brainpower of someone who doesn’t or can’t exercise? Could a protein that gets amplified when people exercise help stave off symptoms of Alzheimer’s and other memory disorders? That’s the tantalizing prospect raised by a new study in which researchers injected sedentary mice with blood from mice that ran for miles on exercise wheels, and found that the sedentary mice then did better on tests of learning and memory. The study, published Wednesday in the journal Nature, also found that the type of brain inflammation involved in Alzheimer’s and other neurological disorders was reduced in sedentary mice after they received their athletic counterparts’ blood. Scientific results with mice don’t necessarily translate to humans. Still, experts said the study supports a growing body of research.

The study involved mice that were about three months old — roughly the equivalent of 25-to-30-year olds for humans. Some of the mice, nocturnal animals that love to run, could freely use exercise wheels in their cages and logged about four to six miles on the wheels each night. The wheels were locked for other mice that could scoot around their cages but could not get an extended cardio workout. […] After 28 days, the researchers took a third group of mice that also did not exercise and injected them with blood plasma, the liquid that surrounds blood cells, from either the runner mice or the non-runner mice. Mice receiving runner blood did better on two tests of learning and memory than those receiving blood from the non-runner mice. In one test, which measures how long a mouse will freeze in fear when it is returned to a cage where it previously received an electric foot shock, mice with runner blood froze 25 percent longer, indicating they had better memory of the stressful event […]. In the other test, mice with runner blood were twice as fast at finding a platform submerged in opaque water, he said. The team also found that the brains of mice with runner blood produced more of several types of brain cells, including those that generate new neurons in the hippocampus, a region involved in memory and spatial learning. A genetic analysis showed that about 1,950 genes had changed in response to the infusion of runner blood, becoming either more or less activated. Most of the 250 genes with the greatest activation changes were involved in inflammation and their changes suggested that brain inflammation was reduced.

Read more of this story at Slashdot.